Adventhealth Translational Research Institute
Clinical trials sponsored by Adventhealth Translational Research Institute, explained in plain language.
-
New study aims to reduce DKA risk for type 1 diabetes patients using SGLT2 inhibitors
Disease control Not yet recruitingThis study tests whether a special education plan using continuous ketone monitoring can lower the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes who also take SGLT2 inhibitors, a drug class that raises DKA risk. About 75 adults with type 1 diabetes will be en…
Phase: PHASE2 • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study tests whether a home-based exercise program can help people with gastrointestinal or lung cancer handle chemotherapy better. Up to 120 participants will be randomly assigned to either an aerobic and resistance exercise group or a stretching group. All activities are do…
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Scientists hunt for hidden signals in muscle cells that could explain insulin resistance
Knowledge-focused Not yet recruitingThis study aims to find new signs in muscle cells that help explain why the body stops responding well to insulin, a condition called insulin resistance. Researchers will study 36 adults aged 30 to 65, including lean individuals and those with obesity, using advanced cell analysi…
Sponsor: AdventHealth Translational Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC